Biotechnology
Breaking News
Healthcare
Market News
Technology
The Market Buzz
Breaking News: Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study
Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) (CSE: AGN) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has submitted for ethics approval in...